Opinion | Price Controls Would Throttle Biomedical Innovation

The speed with which biomedical researchers have raced to develop vaccines and find treatments for the novel coronavirus has been breathtaking. Across the world, nearly 400 unique therapies are under investigation. Fourteen vaccines are in clinical trials. If we’re lucky, one or more will prove safe and effective, paving the way for widespread inoculation against Covid-19.

American biomedical innovation is one of the country’s greatest strengths in the struggle against the virus. But a legislative package moving through Congress…

Subscribe to Newsedgepoint Google News

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *